-
2024-06-17 09:03
-
2024-06-14 22:30
Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas.Ascentage Pharma to receive an option payment of 100 million USD upon closing and be eligible for an option exercise fee and additional po
-
2024-05-14 09:00
-
2024-06-12 18:16
BENGALURU, India, June 12, 2024 /PRNewswire/ -- Infosys(NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that it has been ranked, for the third consecutive year, among the 100 most valuable brands in the worl
-
2024-06-12 14:57
LILLE, France, June 12, 2024 /PRNewswire/ -- Lesaffre, an independent key global player in fermentation and microorganisms, announces today the signing of a transaction with dsm-firmenich, a leading innovator in nutrition, health and beauty, regarding its yeast extract business.L
-
2024-06-11 12:25
SUZHOU, China, and ROCKVILLE, Md., June 11, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the Center for Drug Evaluati
-
2024-06-11 10:00
New Solution of TMR Sensor and 0.4mm-Pitch Magnetic Scale Offers Accurate Linear Displacement Measurement with Excellent Temperature Stability and High Immunity to Stray Field Interference, Achieving Micron-Level Precision for Consumer and Industrial ApplicationsNUREMBERG, German
-
2024-06-10 08:01
-
2024-06-07 17:26
BEIJING, June 7, 2024 /PRNewswire/ --On June 5,iQIYI, a leading online entertainment service in China, hosted the fourth annual Golden Screenwriters' Night, celebrating outstanding screenwriters and their remarkable works. This year's event honored 32 screenwriters and 15 excepti
-
2024-06-07 11:30